REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 33 filers reported holding REDHILL BIOPHARMA LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $74 | -100.0% | 528,673 | -15.3% | 0.00% | – |
| Q3 2022 | $314,000 | -3.1% | 623,892 | +67.3% | 0.00% | – |
| Q2 2022 | $324,000 | -28.3% | 372,930 | +113.0% | 0.00% | – |
| Q4 2021 | $452,000 | +283.1% | 175,058 | +938.7% | 0.00% | – |
| Q3 2019 | $118,000 | -72.4% | 16,853 | -74.3% | 0.00% | -100.0% |
| Q2 2019 | $427,000 | -47.9% | 65,677 | -33.3% | 0.00% | 0.0% |
| Q1 2019 | $819,000 | -51.1% | 98,532 | -67.3% | 0.00% | -66.7% |
| Q4 2018 | $1,674,000 | +6.8% | 301,693 | +69.9% | 0.00% | +50.0% |
| Q3 2018 | $1,568,000 | +606.3% | 177,621 | +582.0% | 0.00% | – |
| Q2 2018 | $222,000 | +318.9% | 26,045 | +152.3% | 0.00% | – |
| Q1 2018 | $53,000 | -75.0% | 10,324 | -47.3% | 0.00% | – |
| Q3 2017 | $212,000 | +19.1% | 19,585 | +42.2% | 0.00% | – |
| Q3 2015 | $178,000 | – | 13,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 444,301 | $2,284,000 | 1.33% |
| 683 Capital Management, LLC | 999,232 | $5,136,000 | 0.43% |
| DAFNA Capital Management LLC | 35,000 | $180,000 | 0.10% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $2,164,000 | 0.08% |
| Migdal Insurance & Financial Holdings Ltd. | 397,324 | $2,042,000 | 0.05% |
| Claret Asset Management Corp | 42,522 | $219,000 | 0.05% |
| Orbimed Advisors | 564,900 | $2,904,000 | 0.04% |
| Altshuler Shaham Ltd | 169,446 | $251,000 | 0.04% |
| Virtu Financial LLC | 60,787 | $312,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 48,000 | $244,000 | 0.01% |